Home/Recalls/CANADA-62274
Health CanadaGeneral Alert

AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Thrombosis with Thrombocyto...

Published: March 24, 2021Recall ID: 62274Category: generalCountry: Canada

Reason for Recall / Hazard

COVID - Product safety

Product Description & Identification

AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Thrombosis with Thrombocytopenia

Additional Source Details

FieldValue
N I D62274
U R Lhttps://recalls-rappels.canada.ca/en/alert-recall/astrazeneca-covid-19-vaccine-and-covishield-risk-thrombosis-thrombocytopenia
IssueCOVID - Product safety
Title AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Thrombosis with Thrombocytopenia
Archived0
CategoryBiologic or vaccine
Last updated2021-03-24
OrganizationMarketed health products

Overview

  • Recalling FirmMarketed health products
Official Agency Alert